Page 353 - IJB-10-2

International Journal of Bioprinting 3D printing with drug for vascular repair

all participants included in our study. Any identifying 12. Chen H, McGowan EM, Ren N, et al. Nattokinase: a promising
information has been appropriately masked to protect the alternative in prevention and treatment of cardiovascular
privacy of the patients. We have made every effort to adhere diseases. Biomark Insights. 2018;13:1177271918785130.
to the consent and privacy guidelines set forth. Therefore, doi: 10.1177/1177271918785130
this requirement is applicable and has been fulfilled. 13. Krisnanda C, Menahem S, Lane GK. Intravascular stent
implantation for the management of pulmonary artery
Availability of data stenosis. Heart Lung Circ. 2013;22(1):56-70.
doi: 10.1016/j.hlc.2012.08.008
The data utilized in this study are available from
the corresponding author (Sang-Mo Kwon, Email: 14. Elens M, Le Fevere de Ten Hove G. In stent re-stenosis after
carotid artery stenting. Eur J Vasc Endovasc Surg. 2023;65(3):378.
smkwon323@pusan.ac.kr) upon reasonable request. doi: 10.1016/j.ejvs.2022.11.026

References 15. John S, Bain MD, Hui FK, et al. Long-term follow-up of
in-stent stenosis after pipeline flow diversion treatment of
1. Pancholy SB, Patel GA, Shah SC, Patel TM. Vascular intracranial aneurysms. Neurosurgery. 2016;78(6):862-867.
complications of the wrist: prevention and management. doi: 10.1227/NEU.0000000000001146
Interv Cardiol Clin. 2020;9(1):87-97. 16. Chiarito M, Mehran R. Panta rhei, also drug eluting stent
doi: 10.1016/j.iccl.2019.08.002 technology. Catheter Cardiovasc Interv. 2020;95(6):1074-1075.
2. Fan J, Watanabe T. Atherosclerosis: known and unknown. doi: 10.1002/ccd.28918
Pathol Int. 2022;72(3):151-160. 17. El-Kadiry AE, Rafei M, Shammaa R. Cell therapy: types,
doi: 10.1111/pin.13202 regulation, and clinical benefits. Front Med (Lausanne).
2021;8:756029.
3. Libby P. The changing landscape of atherosclerosis. Nature.
2021;592(7855):524-533. doi: 10.3389/fmed.2021.756029
doi: 10.1038/s41586-021-03392-8 18. Zhang L, Xu Q. Stem/progenitor cells in vascular regeneration.
Arterioscler Thromb Vasc Biol. 2014;34(6):1114-1119.
4. Balta S. Endothelial dysfunction and inflammatory markers doi: 10.1161/ATVBAHA.114.303809
of vascular disease. Curr Vasc Pharmacol. 2021;19(3):243-249.
doi: 10.2174/1570161118666200421142542 19. Zakrzewski W, Dobrzynski M, Szymonowicz M, Rybak Z.
Stem cells: past, present, and future. Stem Cell Res Ther.
5. Han Y, Li L, Zhang Y, et al. Phenomics of vascular disease: 2019;10(1):68.
the systematic approach to the combination therapy. Curr doi: 10.1186/s13287-019-1165-5
Vasc Pharmacol. 2015;13(4):433-440.
doi: 10.2174/1570161112666141014144829 20. Xie Y, Fan Y, Xu Q. Vascular regeneration by stem/progenitor
cells. Arterioscler Thromb Vasc Biol. 2016;36(5):e33-40.
6. Horvath L, Nemeth N, Feher G, Kívés Z, Endrei D, Boncz I. doi: 10.1161/ATVBAHA.116.307303
Epidemiology of peripheral artery disease: narrative review.
Life (Basel). 2022;12(7):1041. 21. Leeper NJ, Hunter AL, Cooke JP. Stem cell therapy for
doi: 10.3390/life12071041 vascular regeneration: adult, embryonic, and induced
pluripotent stem cells. Circulation. 122(5):517-526.
7. St Hilaire C. Medial arterial calcification: a significant doi: 10.1161/CIRCULATIONAHA.109.881441
and independent contributor of peripheral artery disease.
Arterioscler Thromb Vasc Biol. 2022;42(3):253-260. 22. Bashor CJ, Hilton IB, Bandukwala H, Smith DM, Veiseh O.
doi: 10.1161/ATVBAHA.121.316252 Engineering the next generation of cell-based therapeutics.
Nat Rev Drug Discov. 2022;21(9):655-675.
8. Conte SM, Vale PR. Peripheral arterial disease. Heart Lung doi: 10.1038/s41573-022-00476-6
Circ. 2018;27(4):427-432.
doi: 10.1016/j.hlc.2017.10.014 23. Lovell MJ, Mathur A. Cardiac stem cell therapy: progress
from the bench to bedside. Heart. 2010;96(19):1531-1537.
9. Regmi M, Siccardi MA. Coronary Artery Disease Prevention. doi: 10.1136/hrt.2009.192385
Treasure Island, FL: StatPearls; 2023.
24. Hou YC, Cui X, Qin Z, et al. Three-dimensional bioprinting
10. Pragodpol P, Ryan C. Critical review of factors predicting of artificial blood vessel: process, bioinks, and challenges. Int
health-related quality of life in newly diagnosed coronary J Bioprint. 2023;9(4):740.
artery disease patients. J Cardiovasc Nurs. 2013;28(3):277-284. doi: 10.18063/ijb.740
doi: 10.1097/JCN.0b013e31824af56e
25. Yang GH, Kang D, An S, et al. Advances in the development
11. Lichota A, Szewczyk EM, Gwozdzinski K. Factors affecting of tubular structures using extrusion-based 3D cell-printing
the formation and treatment of thrombosis by natural and technology for vascular tissue regenerative applications.
synthetic compounds. Int J Mol Sci. 2020;21(21):7975. Biomater Res. 2022;26(1):73.
doi: 10.3390/ijms21217975 doi: 10.1186/s40824-022-00321-2

Volume 10 Issue 2 (2024) 345 doi: 10.36922/ijb.1857